Journal of immunotherapy and precision oncology

Keyphrases

Publications

volume 7, number 1, 2024

Carol J Nowlen, Molly Daniels, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Ying Yuan, Keyur P Patel, Nadine Rayes, Jacqueline Harkenrider, Chetna Wathoo, Jennifer Veazie, Krystle A Luna, Wanlin Wang, Chacha Horombe, Milind Javle, Jordi Rodon Ahnert, Timothy A Yap, Banu Arun, Karen H Lu, Funda Meric-Bernstam
Limited Independent Follow-Up with Germline Testing of Variants Detected in BRCA1 and BRCA2 by Tumor-Only Sequencing. Journal of immunotherapy and precision oncology 7 (1) (2024)
Nouran Muhammed Roby, Mohamed Hassan, Mohamed A Aboelkasem, Maha Kamaleldin, Ahmed S Ali
Factors that Influence the Need to Start Adaptive Radiotherapy. Journal of immunotherapy and precision oncology 7 (1) (2024)
Ugur T Sener, Mason James Webb, William G Breen, Bryan J Neth, Nadia N Laack, David Routman, Paul D Brown, Anita Mahajan, Kelsey Frechette, Arkadiusz Z Dudek, Svetomir N Markovic, Matthew S Block, Robert R McWilliams, Anastasios Dimou, Lisa A Kottschade, Heather N Montane, Sani H Kizilbash, Jian L Campian
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma. Journal of immunotherapy and precision oncology 7 (1) (2024)
Kavanya Feustel, Jared Martin, Gerald S Falchook
B7-H3 Inhibitors in Oncology Clinical Trials: A Review. Journal of immunotherapy and precision oncology 7 (1) (2024)
Akanksha Srivastava, Graciela M Nogueras-Gonzalez, Yimin Geng, Jasdev Singh, Jeffrey N Myers, Yisheng Li, Mark S Chambers
Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials. Journal of immunotherapy and precision oncology 7 (1) (2024)
Kyaw Z Hein, Bettzy Stephen, Siqing Fu
Therapeutic Role of Synthetic Lethality in ARID1A -Deficient Malignancies. Journal of immunotherapy and precision oncology 7 (1) (2024)
Akanksha Srivastava, Graciela M Nogueras-Gonzalez, Yimin Geng, Jasdev Singh, Jeffrey N Myers, Yisheng Li, Mark S Chambers
Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials. Journal of immunotherapy and precision oncology 7 (1) (2024)
Harriet Herbison, Sidney Davis, David Nickless, Andrew Haydon, Malaka Ameratunga
Sustained Clinical Response to Immunotherapy Followed by BET Inhibitor in a Patient with Unresectable Sinonasal NUT Carcinoma. Journal of immunotherapy and precision oncology 7 (1) (2024)
Ugur T Sener, Mason James Webb, William G Breen, Bryan J Neth, Nadia N Laack, David Routman, Paul D Brown, Anita Mahajan, Kelsey Frechette, Arkadiusz Z Dudek, Svetomir N Markovic, Matthew S Block, Robert R McWilliams, Anastasios Dimou, Lisa A Kottschade, Heather N Montane, Sani H Kizilbash, Jian L Campian
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma. Journal of immunotherapy and precision oncology 7 (1) (2024)
Ugur T Sener, Mason James Webb, William G Breen, Bryan J Neth, Nadia N Laack, David Routman, Paul D Brown, Anita Mahajan, Kelsey Frechette, Arkadiusz Z Dudek, Svetomir N Markovic, Matthew S Block, Robert R McWilliams, Anastasios Dimou, Lisa A Kottschade, Heather N Montane, Sani H Kizilbash, Jian L Campian
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma. Journal of immunotherapy and precision oncology 7 (1) (2024)
Kavanya Feustel, Jared Martin, Gerald S Falchook
B7-H3 Inhibitors in Oncology Clinical Trials: A Review. Journal of immunotherapy and precision oncology 7 (1) (2024)
Kyaw Z Hein, Bettzy Stephen, Siqing Fu
Therapeutic Role of Synthetic Lethality in ARID1A -Deficient Malignancies. Journal of immunotherapy and precision oncology 7 (1) (2024)
Harriet Herbison, Sidney Davis, David Nickless, Andrew Haydon, Malaka Ameratunga
Sustained Clinical Response to Immunotherapy Followed by BET Inhibitor in a Patient with Unresectable Sinonasal NUT Carcinoma. Journal of immunotherapy and precision oncology 7 (1) (2024)
Akanksha Srivastava, Graciela M Nogueras-Gonzalez, Yimin Geng, Jasdev Singh, Jeffrey N Myers, Yisheng Li, Mark S Chambers
Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials. Journal of immunotherapy and precision oncology 7 (1) (2024)
Nouran Muhammed Roby, Mohamed Hassan, Mohamed A Aboelkasem, Maha Kamaleldin, Ahmed S Ali
Factors that Influence the Need to Start Adaptive Radiotherapy. Journal of immunotherapy and precision oncology 7 (1) (2024)

volume 7, number 2, 2024

Anagha Deshpande, Javier Munoz, Vrushali Dabak, Amr Hanbali, Razelle Kurzrock
Images in Immunotherapy and Precision Oncology: A Case Report of Neurofibromatosis-1. Journal of immunotherapy and precision oncology 7 (2) (2024)
Abdul Rahman Jazieh, Adda Bounedjar, Hikmat Abdel-Razeq, Elif Berna Koksoy, Jawaher Ansari, Arafat H Tfayli, Emad M Tashkandi, Wasil A Jastaniah, Mohamed Osama Alorabi, Amira D Darwish, Ahmed Magdy Rabea, Ashwaq Al Olayan, Fahad Ibnshamsah, Hassan Errihani, Mohammad Omar AlKaiyat, Fazal Hussain, Khaled Alkattan, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Hani Tamim
Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR). Journal of immunotherapy and precision oncology 7 (2) (2024)
Merve Hazal Ser, Mason J Webb, Ugur Sener, Jian L Campian
Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions. Journal of immunotherapy and precision oncology 7 (2) (2024)
Benjamin Duong, Pratyush Banskota, Gerald S Falchook
T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A Review. Journal of immunotherapy and precision oncology 7 (2) (2024)
Jibran Ahmed, Bettzy Stephen, Yali Yang, Evan Kwiatkowski, Chinenye Lynette Ejezie, Shubham Pant
Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies. Journal of immunotherapy and precision oncology 7 (2) (2024)
Anagha Deshpande, Javier Munoz, Vrushali Dabak, Amr Hanbali, Razelle Kurzrock
Images in Immunotherapy and Precision Oncology: A Case Report of Neurofibromatosis-1. Journal of immunotherapy and precision oncology 7 (2) (2024)
Dr Khalid Balaraj
Abstracts Presented at the 2023 Emirates Oncology Conference: November 17-19, 2023, Abu Dhabi, United Arab Emirates. Journal of immunotherapy and precision oncology 7 (2) (2024)
Benjamin Duong, Pratyush Banskota, Gerald S Falchook
T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A Review. Journal of immunotherapy and precision oncology 7 (2) (2024)
Khalid A Jazieh, Lisa Kottschade, Anastasios Dimou
Keeping an Eye Out for Immunotherapy Toxicity: A Case of Unilateral Ptosis Caused by Ipilimumab/Nivolumab Therapy. Journal of immunotherapy and precision oncology 7 (2) (2024)
Merve Hazal Ser, Mason J Webb, Ugur Sener, Jian L Campian
Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions. Journal of immunotherapy and precision oncology 7 (2) (2024)
Jibran Ahmed, Bettzy Stephen, Yali Yang, Evan Kwiatkowski, Chinenye Lynette Ejezie, Shubham Pant
Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies. Journal of immunotherapy and precision oncology 7 (2) (2024)
Khalid A Jazieh, Lisa Kottschade, Anastasios Dimou
Keeping an Eye Out for Immunotherapy Toxicity: A Case of Unilateral Ptosis Caused by Ipilimumab/Nivolumab Therapy. Journal of immunotherapy and precision oncology 7 (2) (2024)
Khalis Mustafayev, Vincent Mallet, Harrys A Torres
Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors. Journal of immunotherapy and precision oncology 7 (2) (2024)
Abdul Rahman Jazieh, Adda Bounedjar, Hikmat Abdel-Razeq, Elif Berna Koksoy, Jawaher Ansari, Arafat H Tfayli, Emad M Tashkandi, Wasil A Jastaniah, Mohamed Osama Alorabi, Amira D Darwish, Ahmed Magdy Rabea, Ashwaq Al Olayan, Fahad Ibnshamsah, Hassan Errihani, Mohammad Omar AlKaiyat, Fazal Hussain, Khaled Alkattan, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Hani Tamim
Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR). Journal of immunotherapy and precision oncology 7 (2) (2024)
Khalis Mustafayev, Vincent Mallet, Harrys A Torres
Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors. Journal of immunotherapy and precision oncology 7 (2) (2024)

volume 7, number 3, 2024

Diogo J Silva, Blessie Elizabeth Nelson, Jordi Rodon
Decentralized Clinical Trials in Early Drug Development-A Framework Proposal. Journal of immunotherapy and precision oncology 7 (3) (2024)
Abdul Rahman Jazieh, Nihal El Rouby, Andrew Guinigundo, Karen M Huelsman, Emily Curran, Rafiullah Khan, Jaime Grund, Alejandro R Calvo, Jason J Claes, Sarah C Overton, Sally Hellard, Leah Vasiliadis, Minetta Liu, Burns C Blaxall
A Systematic Approach to Optimize the Implementation of Precision Oncology in Clinical Practice: A Meeting Proceeding. Journal of immunotherapy and precision oncology 7 (3) (2024)
Mirella Nardo, Camila Bragança Xavier, Fabio Franke
Phase 1 Clinical Trials: Challenges and Opportunities in Latin America. Journal of immunotherapy and precision oncology 7 (3) (2024)
David M Hein, Laura A Coughlin, Nicole Poulides, Andrew Y Koh, Nina N Sanford
Assessment of Distinct Gut Microbiome Signatures in a Diverse Cohort of Patients Undergoing Definitive Treatment for Rectal Cancer. Journal of immunotherapy and precision oncology 7 (3) (2024)
Diogo J Silva, Blessie Elizabeth Nelson, Jordi Rodon
Decentralized Clinical Trials in Early Drug Development-A Framework Proposal. Journal of immunotherapy and precision oncology 7 (3) (2024)
Hawazin Alotaibi, Amna M Anis, Abdurahman Alloghbi, Kanan Alshammari
Oncology Early-Phase Clinical Trials in the Middle East and North Africa: A Review of the Current Status, Challenges, Opportunities, and Future Directions. Journal of immunotherapy and precision oncology 7 (3) (2024)
Abdul Rahman Jazieh, Nihal El Rouby, Andrew Guinigundo, Karen M Huelsman, Emily Curran, Rafiullah Khan, Jaime Grund, Alejandro R Calvo, Jason J Claes, Sarah C Overton, Sally Hellard, Leah Vasiliadis, Minetta Liu, Burns C Blaxall
A Systematic Approach to Optimize the Implementation of Precision Oncology in Clinical Practice: A Meeting Proceeding. Journal of immunotherapy and precision oncology 7 (3) (2024)
Razelle Kurzrock, David Hong
How to Build a Successful Phase I Clinical Trials Unit: Lessons Based on the MD Anderson Cancer Center Experience. Journal of immunotherapy and precision oncology 7 (3) (2024)
Sewanti Limaye, Mohan Menon, Shambhavi Singh, Pritam Kataria, Aditya V Shreenivas, Rajan Datar, Darshana Patil, Prashant Kumar, Niyati Shah, Hardik Sheth, Suku Sneha, Chetan Madre, Ruturaj Deshpande, Narayan K Menon, Prasad Dandekar, Vijay Haribhakti
Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy. Journal of immunotherapy and precision oncology 7 (3) (2024)
Sewanti Limaye, Mohan Menon, Shambhavi Singh, Pritam Kataria, Aditya V Shreenivas, Rajan Datar, Darshana Patil, Prashant Kumar, Niyati Shah, Hardik Sheth, Suku Sneha, Chetan Madre, Ruturaj Deshpande, Narayan K Menon, Prasad Dandekar, Vijay Haribhakti
Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy. Journal of immunotherapy and precision oncology 7 (3) (2024)
David M Hein, Laura A Coughlin, Nicole Poulides, Andrew Y Koh, Nina N Sanford
Assessment of Distinct Gut Microbiome Signatures in a Diverse Cohort of Patients Undergoing Definitive Treatment for Rectal Cancer. Journal of immunotherapy and precision oncology 7 (3) (2024)
Anagha Deshpande, Javier Munoz, Razelle Kurzrock
Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma. Journal of immunotherapy and precision oncology 7 (3) (2024)
Hawazin Alotaibi, Amna M Anis, Abdurahman Alloghbi, Kanan Alshammari
Oncology Early-Phase Clinical Trials in the Middle East and North Africa: A Review of the Current Status, Challenges, Opportunities, and Future Directions. Journal of immunotherapy and precision oncology 7 (3) (2024)
Prajwal Dhakal, Mario Sy, Grerk Sutamtewagul, Eric Mou, Nanmeng Yu, Naveen Pemmaraju
Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting. Journal of immunotherapy and precision oncology 7 (3) (2024)
Liyun Jiang, Zhulin Yin, Fangrong Yan, Ying Yuan
MC-Keyboard: A Practical Phase I Trial Design for Targeted Therapies and Immunotherapies Integrating Multiple-Grade Toxicities. Journal of immunotherapy and precision oncology 7 (3) (2024)
Prajwal Dhakal, Mario Sy, Grerk Sutamtewagul, Eric Mou, Nanmeng Yu, Naveen Pemmaraju
Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting. Journal of immunotherapy and precision oncology 7 (3) (2024)
Mirella Nardo, Camila Bragança Xavier, Fabio Franke
Phase 1 Clinical Trials: Challenges and Opportunities in Latin America. Journal of immunotherapy and precision oncology 7 (3) (2024)
Anagha Deshpande, Javier Munoz, Razelle Kurzrock
Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma. Journal of immunotherapy and precision oncology 7 (3) (2024)
Razelle Kurzrock, David Hong
How to Build a Successful Phase I Clinical Trials Unit: Lessons Based on the MD Anderson Cancer Center Experience. Journal of immunotherapy and precision oncology 7 (3) (2024)
Liyun Jiang, Zhulin Yin, Fangrong Yan, Ying Yuan
MC-Keyboard: A Practical Phase I Trial Design for Targeted Therapies and Immunotherapies Integrating Multiple-Grade Toxicities. Journal of immunotherapy and precision oncology 7 (3) (2024)